← All stocks

BioXcel Therapeutics, Inc.

BTAI Net selling
CIK 0001720893 #4965 in the set updated 17 Sep 2026
Bought (120 mo)
$321.11K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$75.03M
$447.41K on a plan · $12.63M straight out of an exercise
Sold at will
$61.95M
23 of 106 sales
Net
−$74.70M
−$61.63M against sales at will

By person

11 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mehta Vimal
CEO and President
$89.34K (21)
$18.86M (30)
−$18.77M
25,484,068
$27.70M
−7.8%
Nandabalan Krishnan
Director
$4.92K (1)
$17.85M (8)
−$17.84M
17,727,750
$19.27M
−4.6%
BioXcel Holdings, Inc. entity
10% owner
$14.59M (1)
−$14.59M
17,566,750
$19.10M
−3.5%
BioXcel LLC entity
10% owner
$14.59M (1)
−$14.59M
8,546,750
$9.29M
−6.9%
O'Neill Vincent
See Remarks
$4.82M (21) scheduled
−$4.82M
19,957
$21.69K
Yocca Frank
Chief Scientific Officer
$66.31K (5)
$3.85M (22)
−$3.79M
26,210
$28.49K
Steinhart Richard I
Chief Financial Officer
$7.60K (3)
$372.18K (10) scheduled
−$364.58K
26,335
$28.63K
MUELLER PETER
Director
$152.94K (12)
+$152.94K
258,320
$280.79K
+9.7%
Rodriguez Javier
See Remarks
$81.81K (9) scheduled
−$81.81K
26,838
$29.17K
Wiley Matthew T.
See Remarks
$6.56K (4) scheduled
−$6.56K
19,011
$20.66K
+1,801%
MACK DAVID J.
Director
20,317
$22.08K

No percentages here. This company's share count has moved by a factor of 7.8 over the window, from 5,486,038 to 42,748,364 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mehta Vimal
20 May 2026
CEO and President
Sold on a plan
19,419
$1.09
$21.11K
Steinhart Richard I
20 May 2026
Chief Financial Officer
Sold on a plan
6,845
$1.09
$7.43K
Rodriguez Javier
20 May 2026
See Remarks
Sold on a plan
6,560
$1.08
$7.11K
Yocca Frank
20 May 2026
Chief Scientific Officer
Sold on a plan
6,845
$1.09
$7.43K
Yocca Frank
16 Dec 2024
Chief Scientific Officer
Sold on a plan
225
$0.35
$79.02
Yocca Frank
16 Dec 2024
Chief Scientific Officer
Sold on a plan
205
$0.36
$72.80
Rodriguez Javier
16 Dec 2024
See Remarks
Sold on a plan
220
$0.36
$78.47
Rodriguez Javier
16 Dec 2024
See Remarks
Sold on a plan
210
$0.36
$74.55
Steinhart Richard I
16 Dec 2024
Chief Financial Officer
Sold on a plan
372
$0.36
$133.18
Steinhart Richard I
16 Dec 2024
Chief Financial Officer
Sold on a plan
205
$0.36
$73.80
Mehta Vimal
16 Dec 2024
CEO and President
Sold on a plan
2,134
$0.36
$773.36
Mehta Vimal
16 Dec 2024
CEO and President
Sold on a plan
983
$0.36
$357.91
O'Neill Vincent
16 Dec 2024
See Remarks
Sold on a plan
165
$0.35
$58.13
O'Neill Vincent
3 Oct 2024
See Remarks
Sold on a plan
5,556
$0.55
$3.06K
Steinhart Richard I
3 Oct 2024
Chief Financial Officer
Sold on a plan
7,175
$0.55
$3.95K
Yocca Frank
3 Oct 2024
Chief Scientific Officer
Sold on a plan
7,175
$0.55
$3.95K
Rodriguez Javier
3 Oct 2024
See Remarks
Sold on a plan
6,863
$0.55
$3.77K
Wiley Matthew T.
3 Oct 2024
Chief Commercial Officer
Sold on a plan
6,272
$0.55
$3.45K
Wiley Matthew T.
16 Sep 2024
Chief Commercial Officer
Sold on a plan
215
$0.69
$148.52
O'Neill Vincent
16 Sep 2024
See Remarks
Sold on a plan
138
$0.69
$95.33
Rodriguez Javier
16 Sep 2024
See Remarks
Sold on a plan
345
$0.69
$238.05
Steinhart Richard I
16 Sep 2024
Chief Financial Officer
Sold on a plan
356
$0.69
$245.60
Mehta Vimal
16 Sep 2024
CEO and President
Sold on a plan
1,150
$0.69
$794.08
Mehta Vimal
16 Sep 2024
CEO and President
Sold on a plan
832
$0.69
$572.83
Yocca Frank
16 Sep 2024
Chief Scientific Officer
Sold on a plan
355
$0.69
$244.70
Mehta Vimal
17 Jun 2024
CEO and President
Sold on a plan
2,134
$1.28
$2.74K
O'Neill Vincent
17 Jun 2024
See Remarks
Sold on a plan
155
$1.29
$199.18
Rodriguez Javier
17 Jun 2024
See Remarks
Sold on a plan
361
$1.26
$456.02
Steinhart Richard I
17 Jun 2024
Chief Financial Officer
Sold on a plan
372
$1.26
$469.54
Wiley Matthew T.
17 Jun 2024
Chief Commercial Officer
Sold on a plan
244
$1.26
$308.10
Yocca Frank
17 Jun 2024
Chief Scientific Officer
Sold on a plan
372
$1.28
$476.16
Yocca Frank
4 Apr 2024
Chief Scientific Officer
Sold on a plan
1,067
$2.64
$2.81K
Rodriguez Javier
4 Apr 2024
See Remarks
Sold on a plan
1,012
$2.64
$2.67K
Wiley Matthew T.
4 Apr 2024
CHIEF COMMERCIAL OFFICER
Sold on a plan
1,008
$2.64
$2.66K
Steinhart Richard I
4 Apr 2024
Chief Financial Officer
Sold on a plan
1,069
$2.64
$2.82K
Mehta Vimal
4 Apr 2024
CEO and President
Sold on a plan
4,439
$2.62
$11.65K
Mehta Vimal
4 Apr 2024
CEO and President
Sold on a plan
829
$2.62
$2.17K
O'Neill Vincent
4 Apr 2024
See Remarks
Sold on a plan
165
$2.62
$432.48
Mehta Vimal
22 May 2023
CEO and President
Sold on a plan
6,500
$25.79
$167.64K
Rodriguez Javier
15 May 2023
See Remarks
Sold on a plan
1,785
$27.32
$48.76K
Steinhart Richard I
15 May 2023
Chief Financial Officer
Sold on a plan
5,000
$27.17
$135.86K

What was left out

Form 4 filings counted 230
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 41
Sales straight out of an exercise 42
Sales at will 23
Transactions with no price 3
Shares from compensation/vesting 2,968,409
Sales filed before the plan box existed 18
History held since 13 Mar 2018